Overview

Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) immediately after vaginal delivery compared to 4-8 weeks later. The investigators hypothesize there will be no difference in breastfeeding prevalence between the two groups.
Phase:
Phase 4
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
Society of Family Planning
Treatments:
Levonorgestrel